by Dan Roberts with additional material by Wendy Strouse Watt, O.D. Originally Published October 26, 2005 Acuity Medical has successfully completed a proof of concept, double-masked trial of its TheraMac™ device for the treatment of dry age-related macular degeneration (AMD). The therapy developed from early studies of microcurrent stimulation, with improvements in the science and [Read More]
by Dan Roberts Originally posted on MDSupport and updated in September 2005: QLT’s preliminary results found that Visudyne in an occult trial did not achieve its primary endpoint after two years. ———————————– Photodynamic therapy has been shown to be effective in helping to prevent further loss of sight in people who are afflicted by the [Read More]
by Wendy Strouse Watt, O.D. November 2003 Retinal telangiectasias are a group of rare, idiopathic (a disease having no known cause), congenital retinal vascular anomalies affecting the retinal capillaries. The conditions are characterized by dilation and tortuosity of retinal vessels and formation of multiple aneurysms (localized, pathological, blood-filled dilatations of a blood vessel caused by [Read More]
by Wendy Strouse Watt, O.D. Originally published October 2003 People who spend more than two hours on a computer each day will experience symptoms of CVS or Computer Vision Syndrome. The most common symptoms include headaches, focusing difficulties, burning eyes, tired eyes, general eyestrain, aching eyes, dry eyes, double vision, blurred vision, light sensitivity, and [Read More]
